Eric Halioua
(MS, MBA), Chief Executive Officer
President of the Board
e.halioua@pdc-line-pharma.com

http://www.pdc-line-pharma.com
CHU - Tour 5 (B34) – GIGA, Avenue de l'Hôpital 11
4000 LIEGE
Belgium

Eric is as well President of Digital Orthopaedics and Board member of the biotechnology company Bioxodes (Belgium), VitriCell (Belgium) and Innobiochips (France). Eric is a serial entrepreneur that raised more than €100 million over the course of his career and has had numerous successes in the sale and IPO of biotechnology companies. Eric former CEO of Promethera Biosciences and co-founder of three biotechnology called Myosix (bought by Genzyme mid-2002), Murigenetics and Digital Orthopaedics. Eric worked for 12 years as a Principal in the Healthcare and Life Sciences Practice of Arthur D. Little.  Eric holds two master degrees in Pharmacology and Molecular Biology and a MBA from ESSEC business school (Paris).